Portfolio Update

RNS Number : 8421F

Intl. Biotechnology Trust PLC

22 May 2017

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)

Portfolio Update as at 30 April 2017

Net Assets	£238m
Net Assets per share	633p
Share price	586p
Total value of unquoted investments	£23m
Total number of portfolio companies	91
Dividend	4% of NAV per annum

Top Ten Quoted Investments

Company Name	% NAV
Celgene	7.9
Regeneron	5.7
Alexion	5.2
Genmab	5.0
Vertex	5.0
Biogen	3.3
Incyte	3.1
Amgen	2.6
Biomarin	2.4
Acadia	2.3
	-----------
Total	42.5

Geographical Allocation	% NAV
US & Canada	85
Europe & UK	15
	-----------
Total	100

Quoted/Unquoted Allocation	% NAV
Quoted	90
Unquoted	10
	-----------
Total	100

NAV % Market Cap	% NAV
Large Cap >USD10BN	48
Mid Cap =USD1-10BN	27
Small Cap <USD1BN	25
	-----------
Total	100

NAV % by Therapeutic Areas	% NAV
Oncology	36
Orphan	14
CNS	13
Ophthalmology	8
Inflammation	5
Medtech	2
Other	22
	-----------
Total	100

BNP Paribas Secretarial Services Limited

Company Secretary

22 MAY 2017

 

END

 

 

PFUBGGDUCSDBGRD